SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SSgA Active Trust - SPDR S&P 500 ETF Trust

The SPDR S&P 500 ETF Trust is trending as President Trump's threats of new tariffs on European nations over Greenland escalate geopolitical tensions, leading to a risk-off market sentiment. The community is divided, with some anticipating a significant market pullback, while others view it as a 'buy the dip' opportunity, also noting a Japan-led bond sell-off as a contributing factor. This environment is fueling discussions about broader market volatility and a flight to safe-haven assets.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending following constructive discussions with the FDA regarding a resubmission path for ANKTIVA in bladder cancer, complemented by significant international approvals and strategic partnerships like those recently established in Saudi Arabia for broader cancer indications. This development, coupled with high short interest, is fueling widespread community excitement about a potential paradigm shift in oncology and intense speculation regarding a short squeeze amidst growing calls for expedited access to these innovative treatments.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ is actively trending amid escalating US-EU trade tensions driven by President Trump's tariff threats over Greenland, sparking a widespread market sell-off and global risk-off sentiment. The investment community is sharply divided between those anticipating a deeper correction for technology and growth stocks and fervent "buy the dip" proponents. Immediate market focus remains on an upcoming Supreme Court ruling regarding tariff authority and a heavy week of earnings reports, amplifying uncertainty.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is a major talking point following its J.P. Morgan conference appearance, where investors are eagerly seeking clarity on its strategy for advancing the Matrix-M adjuvant technology and securing new collaborations. Community sentiment is sharply focused on management's pace in realizing pipeline potential, including a recent Pfizer agreement and ongoing Sanofi ventures, with an activist investor's growing stake and significant short interest adding to the intense market watch.

Corvus Pharmaceuticals, Inc. engages in the development of immune modulator product candidates with the potential to treat solid cancers, T-cell lymphomas, autoimmune diseases, and infectious diseases. Its product pipeline includes B Cell Activator and Anti-CD73, Adenosine Production Inhibitor Anti-CD73, ITK Inhibitor, A2AR Inhibitor, Anti-CXCR2, and A2BR Inhibitor. The company was founded by Richard A. Miller, Peter A. Thompson, Joseph J. Buggy, and Erik Verner on January 27, 2014 and is headquartered in South San Francisco, CA.

Corvus Pharmaceuticals Inc

Corvus Pharmaceuticals is trending after announcing positive data from its placebo-controlled Phase 1 clinical trial of soquelitinib for atopic dermatitis, showing strong efficacy. The community is actively discussing the oral ITK inhibitor's potential in a large market, with many anticipating significant revaluation and partnership opportunities for its novel mechanism of action.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is gaining significant attention as its patented Optical Interposer platform is seen as crucial for next-generation AI and data center infrastructure, enabling highly efficient and scalable optical interconnects. The community is actively discussing recent product innovation awards and confirmed partnerships, including with Celestial AI (now Marvell), which validate its technology. Anticipation is also building for the imminent disclosure of major institutional investors, signaling strong long-term confidence.

BlackRock Institutional Trust Company N.A. - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

TLT is trending amid intense debate surrounding the Federal Reserve's independence, fueled by a federal probe into its Chair and the administration's aggressive policy maneuvers impacting bond markets. Investors are actively discussing whether long-term treasuries offer a crucial hedge against a potential economic slowdown or face further headwinds from escalating national debt and geopolitical uncertainty.

Ardelyx, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing biopharmaceutical products. The firm is also involved in developing a unique and innovative platform that enables the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet in October 2007 and is headquartered in Waltham, MA.

Ardelyx Inc

Ardelyx is trending as investors react to a significant patent extension for its key products until 2041, coupled with a bullish preliminary business update accelerating IBSRELA's path to $1 billion in revenue by 2029 and multiple analyst price target upgrades. The community is buzzing with renewed acquisition speculation and optimism over the company's long-term value, despite ongoing discussions about short-term price fluctuations attributed to market dynamics. This confluence of positive developments has many viewing Ardelyx as a significantly undervalued biotech with strong commercial execution.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

Applovin (APP) is actively trending amid recent allegations of money laundering and illicit financial ties, triggering a sharp sell-off across the stock. Despite this, community sentiment is divided, with many dismissing the claims as a coordinated short attack ahead of strong earnings, while others are seizing the opportunity to buy into the fundamentally strong AI-powered ad platform.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group Corp. (DJT) is seeing heightened conversation due to recent developments surrounding Trump's assertive stance on Greenland and reactions to a perceived Nobel Peace Prize snub, which has sparked discussions of new tariffs on European nations. The community is actively debating the potential for increased market volatility, geopolitical instability, and the broader economic ramifications of these actions. This ongoing dialogue underscores intense political polarization and its influence on market sentiment.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>Goldman Sachs began coverage of Stellantis with a ‘Neutral’ rating and said it shares the “attractive value” seen across undervalued premium automakers.</li><li>The firm highlighted sector pressures from Chinese competition, electric-vehicle momentum and tightening European Union rules.</li><li>BMW, Mercedes-Benz, Renault, Ferrari, Volkswagen, Porsche AG and Aston Martin Lagonda were all initiated with varying upside or downside expectations.</li></ul>Stellantis&nbsp;NV offers the same “attractive value” Goldman Sachs sees across Europe’s premium automakers, the bank’s research arm said as it initiated coverage of several carmakers during what it described as “tumultuous times” for the sector. Goldman began coverage of Stellantis with a ‘Neutral’ rating and a $10 price target, implying a 1.3% upside from the last close. The firm said Stellantis shares its valuation appeal, identifying the most undervalued areas of the European auto industry.<h2 class="st-heading-2">Goldman Flags Market Pressure&nbsp;</h2>Goldman said European automakers face growing pressure as Chinese manufacturers expand globally and battery electric vehicle momentum accelerates. The firm added that European Union tariffs, currency swings, and tightening emissions rules are adding further strain. Goldman noted that BMW, Mercedes, Volkswagen and Renault now trade at negative industrial stub valuations, which it called “premature,” and said the premium segment remains the most undervalued part of the market.<h2 class="st-heading-2">Automakers Goldman Sees As Attractive Value Opportunities</h2>Goldman highlighted several automakers that it believes offer meaningful upside. The company initiated BMW with a ‘Buy’ rating and a 112 euro price target, implying a 32% upside. Mercedes-Benz was also initiated with a ‘Buy’ rating and a 74 euro price target, representing a 30% upside. Goldman said it likes both BMW and Mercedes-Benz for their “healthy” balance sheets and “shareholder-friendly” capital allocation frameworks.The bank initiated Ferrari with a ‘Buy’ rating and a $454 price target, giving the stock a 35% upside. Goldman said Ferrari’s higher-priced Special Series volumes support stronger selling prices and growth.Goldman also said Renault offers the same “attractive value” seen across premium automakers. The firm began coverage with a ‘Neutral’ rating and a 36-euro price target, implying a 5% upside.&nbsp;<h2 class="st-heading-2">Automakers Goldman Views More Cautiously</h2>Goldman initiated coverage of Volkswagen with a ‘Neutral’ rating and a 106-euro price target, giving it a 12% upside. Porsche AG was also initiated at a ‘Neutral’ rating with a 46 euro price target, representing a 29% upside.Aston Martin Lagonda received a ‘Neutral’ rating and a 61-pound price target, which reflects a 1% downside. The bank’s research arm highlighted structural concerns over Aston Martin’s balance sheet.<h2 class="st-heading-2">Stocktwits Traders Back Stellantis, BMW, Renault&nbsp;</h2>On Stocktwits, automakers including Stellantis, BMW, Mercedes-Benz, and Renault all saw ‘bullish’ sentiment, though message volume was ‘high’ for Stellantis, ‘normal’ for BMW and Renault, and ‘low’ for Mercedes-Benz.Porsche AG and Aston Martin Lagonda each recorded ‘neutral’ sentiment, with Porsche seeing ‘low’ message volume while Aston Martin registered ‘normal’ activity. Among the outliers, Ferrari drew ‘bearish’ sentiment on ‘low’ message volume, while Volkswagen saw ‘extremely bearish’ sentiment, also amid ‘low’ message volume.So far this year, performance across U.S.-listed European automakers has been mixed.&nbsp;<a href="https://stocktwits.com/symbol/STLA">Stellantis</a> is down 19%, Renault is down 15%, Ferrari is down 8%, and Aston Martin Lagonda is down 38%. Meanwhile, several peers have gained ground, with&nbsp;<a href="https://stocktwits.com/symbol/BMWYY">BMW</a> up 25%,&nbsp;<a href="https://stocktwits.com/symbol/MBGAF">Mercedes-Benz</a> up 26%,&nbsp;<a href="https://stocktwits.com/symbol/VLKAY">Volkswagen</a> up 26% and&nbsp;<a href="https://stocktwits.com/symbol/POAHY">Porsche</a> up 14% year to date.For updates and corrections, email newsroom[at]stocktwits[dot]com.

A view of the historical FIAT plant in Turin, Italy. (Photo by Mauro Ujetto/NurPhoto via Getty Images)

Stellantis Stock Joins Undervalued Premium Peers In Goldman’s ‘Attractive Value’ Call Despite Sector Turbulence

The firm highlighted sector pressures from Chinese competition, electric-vehicle momentum and tightening European Union rules.

Equity

Aston Martin shares slid more than 3% in London on Wednesday after the British luxury carmaker cut its 2025 profit outlook, blaming "evolving and disruptive" U.S. auto tariffs.Under a U.S.-UK trade deal implemented in May, the first 100,000 UK car imports are subject to a 10% tariff, while any shipments exceeding that threshold are subject to a 27.5% duty. Aston Martin stated that the quota system is hindering its ability to forecast results and could impact margins into 2026."We continue to actively engage the UK government to urge them to improve the quota mechanism to ensure fair access for the whole UK car industry to the 10% rate on an ongoing basis," CEO Adrian Hallmark said in a statement.The company now expects its gross margin this year to be broadly in line with last year's 37%, which is below its prior target of 40%. Adjusted earnings before interest and tax (EBIT) may no longer turn positive in 2025, instead moving toward breakeven.For the latest quarter, Aston Martin posted an adjusted operating loss of £57 million&nbsp;($76.16 million) versus a £42.7 million loss a year ago. Revenue fell 34% to £220.5 million, below the consensus of £270 million. Wholesale volumes dropped 8% to 972 units, while retail deliveries outpaced wholesales by over 40%.The broader UK auto industry is also reeling, with output&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://www.cnbc.com/2025/06/27/trump-tariffs-uk-car-and-vehicle-output-falls-to-76-year-low-in-may.html#:~:text=The%20U.K.'s%20new%20car,level%20since%201949%20in%20May.">reportedly</a> at its lowest level since 1949, as exports have paused amid Trump's tariffs.&nbsp;Aston Martin’s London-listed shares are down 26% year-to-date, while its over-the-counter stock in the U.S. has fallen nearly 14%.On Stocktwits, retail sentiment toward Aston Martin remains 'bearish' amid 'high' message volume late Tuesday.(£1 = $1.34)For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/li-auto-just-launched-its-first-electric-suv-here-s-why-investors-are-already-backing-off/choQ86IR5yy">Li Auto Just Launched Its First Electric SUV: Here’s Why Investors Are Already Backing Off</a>

An Aston Martin Vantage is displayed in the Mayfair showroom on Park Lane on January 09, 2025 in London, England. (Photo by John Keeble/Getty Images)

Aston Martin Wants UK To Tweak Trump Trade Deal After Cutting 2025 Targets On 'Disruptive' Auto Tariffs

Adjusted earnings before interest and tax (EBIT) may no longer turn positive in 2025, the company said, instead moving toward breakeven.

Aston Martin Lagonda Global Holdings Plc engages in the business of designing, creating, and exporting cars. Its current models include the Vantage, dB12, Vanquish, DBX707, Valhalla, Valkyrie, Valour, Valiant amd AMR25 F1. The company was founded by Robert Bamford and Lionel Martin on January 15, 1913 and is headquartered in Warwick, the United Kingdom.

AMGDF
Aston Martin Lagonda Global Holdings Plc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest AMGDF News

AMGDFAston Martin Lagonda Global Holdings Plc